Past Events

Apitope International N.V., the biopharmaceutical company developing peptide therapies for autoimmune diseases, is pleased to announce that Dr. Keith Martin, CEO, will provide an update on Apitope (antigen processing independent epitope autoimmune vaccines) at the symposium on “Therapeutic & Preventative Vaccines for Autoimmune Diseases: Scientific & Commercial Opportunities”, sponsored by the Juvenile Diabetes Research Foundation and…

Apitope International N.V., the autoimmune peptide therapy company, announces today that Dr. Keith Martin, CEO,will give an overview of the Company’s business at ‘BioEquity Europe 2010’. The presentation will be at the Swissôtel Zurich, Switzerland at 15.30 (CET) on Wednesday, 19 May 2010. The presentation will focus on Apitope’s development of therapeutic peptides for revolutionary…

Apitope International N.V., the autoimmune peptide therapy company, announced today that Dr. Keith Martin, CEO, will give an overview of the Company’s business at ‘The Peptide Conference’. The presentation will be at The Wellcome Trust Conference Centre, Cambridge, UK at 4pm (BST) on Tuesday, 30th March 2010. The presentation will provide an insight into how…